Recent studies have reported the presence of natural humoral and cellular immunity against Ror1 in chronic lymphocytic leukemia (CLL) patients23 and expression of high levels of Ror1 may promote cancer cell activation and survival enhancing disease progression in patients suffering from CLL24. The gene discussed is ROR1; the disease is cancer.